Language

News topic

Active ingredient RIVAROXABAN

Current shortage notices for the active ingredient RIVAROXABAN, structured by product, country and reporting period.

9 notices

← All shortages

What the RIVAROXABAN notices indicate for the supply chain

The 9 consolidated notices from Austria, Belgium, Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Austria

Rivaroxaban +pharma 2,5 mg Filmtabletten

Active ingredient: RIVAROXABAN

View notice details →
Austria

Rivaroxaban Genericon 2,5 mg Filmtabletten

Active ingredient: RIVAROXABAN

View notice details →
Belgium

Rivaroxaban Viatris 15 mg - 20 mg filmomh. tabl. 49 (42 (15 mg) + 7 (20 mg))

Active ingredient: Rivaroxaban; Rivaroxaban

View notice details →
Germany

Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen

Active ingredient: Rivaroxaban

View notice details →
Austria

Rivaroxaban ratiopharm 20 mg Filmtabletten

Active ingredient: RIVAROXABAN

View notice details →
Austria

Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen

Active ingredient: RIVAROXABAN

View notice details →